Anatara Lifesciences with Proactive at ASX Small and Mid-Cap Conference

Proactive
8 September 2020
By mailto:andrew.scott@proactiveinvestors.com

“Anatara Lifesciences Ltd (ASX:ANR) chief executive officer Steve Lydeamore speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap conference 2020.The life sciences company is developing and commercialising innovative, evidence-based products for gastrointestinal…”

Please click on the link below for the full article:
https://www.proactiveinvestors.com.au/companies/news/928473/anatara-lifesciences-with-proactive-at-asx-small-and-mid-cap-conference-928473.html